Literature DB >> 31104837

Does Surgeon Fellowship Training Influence Outcomes in Hemiarthroplasty for Femoral Neck Fracture?

Scott E Mabry1, Kyle H Cichos1, James T McMurtrie1, Jeffrey M Pearson1, Gerald McGwin2, Elie S Ghanem1.   

Abstract

BACKGROUND: The aim of this study is to compare the outcomes (90 days and 1 year) of patients with femoral neck fracture undergoing hemiarthroplasty by surgeons with different fellowship training: trauma, arthroplasty, and general orthopedics.
METHODS: This study is a retrospective review of consecutive patients undergoing hip hemiarthroplasty for femoral neck fracture from 2010 to 2018. Comorbidities, perioperative details, demographics, injury variables, and time-to-surgery were compared between the fellowship training cohorts, in addition to outcomes including dislocation, periprosthetic joint infection, and mortality at 90 days and 1 year.
RESULTS: A total of 298 hips with an average age of 77.8 years underwent hemiarthroplasty for femoral neck fracture. Arthroplasty surgeons had a significantly shorter operative duration (82 minutes, P = .0014) and utilized the anterior approach more frequently (P < .0001). The general orthopedists had a significantly increased total surgical complication risk compared to both the arthroplasty and trauma fellowship-trained cohorts at both 90 days (11.8% vs 1.6% vs 3.9%, P = .015) and 1 year (18.2% vs 4.9% vs 7.1%, P = .008). The overall mortality risk was 11.7% at 90 days and 22.8% at 1 year. When adjusted for covariates, including comorbidities, gender, age, and preoperative walking capacity, both the arthroplasty fellowship-trained cohort (odds ratio 0.381, 95% confidence interval 0.159-0.912, P = .030) and the general orthopedist cohort (odds ratio 0.495; 95% confidence interval 0.258-0.952, P = .035) had reduced risk of 1-year mortality compared to the trauma fellowship-trained cohort.
CONCLUSION: Hemiarthroplasty performed for femoral neck fractures may result in fewer complications when performed by arthroplasty fellowship-trained surgeons. An arthroplasty weekly on-call schedule and adjusted institutional protocols may be utilized to improve outcomes and reduce complications. LEVEL OF EVIDENCE: Level II, retrospective cohort.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fellowship; femoral neck fracture; hip hemiarthroplasty; outcomes; surgeon training

Year:  2019        PMID: 31104837     DOI: 10.1016/j.arth.2019.04.038

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  Subspecialty Fellowship Training Is Not Associated With Better Outcomes in Fixation of Low-Energy Femoral Neck Fractures-An Analysis of the Fixation Using Alternative Implants for the Treatment of Hip Fractures Database.

Authors:  Ryan D DeAngelis; Matthew K Stein; Gregory T Minutillo; Nikhilesh G Mehta; Emil H Schemitsch; Sofia Bzovsky; Sheila Sprague; Mohit Bhandari; Marc Swiontkowski; Derek J Donegan; Samir Mehta
Journal:  J Orthop Trauma       Date:  2022-04-01       Impact factor: 2.512

2.  Comparative Analysis of Total Knee Arthroplasty Outcomes Between Arthroplasty and Nonarthroplasty Fellowship Trained Surgeons.

Authors:  Vivek Singh; Trevor Simcox; Vinay K Aggarwal; Ran Schwarzkopf; William J Long
Journal:  Arthroplast Today       Date:  2021-02-26

3.  Association Between COVID-19 and Mortality in Hip Fracture Surgery in the National COVID Cohort Collaborative (N3C): A Retrospective Cohort Study.

Authors:  Eli B Levitt; David A Patch; Scott Mabry; Alfredo Terrero; Byron Jaeger; Melissa A Haendel; Christopher G Chute; Jonathan H Quade; Brent Ponce; Steven Theiss; Clay A Spitler; Joey P Johnson
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-01-04

4.  The case for decreased surgeon-reported complications due to surgical volume and fellowship status in the treatment of geriatric hip fracture: An analysis of the ABOS database.

Authors:  Taylor D Ottesen; Michael R Mercier; Jordan Brand; Michael Amick; Jonathan N Grauer; Lee E Rubin
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.